Podcast TCTMD Talking Points FAME 2: 3-Year Clinical and Cost-Effectiveness Outcomes of FFR-Guided PCI in Patients With Coronary Artery Disease September 05, 2018
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for August 2018 Caitlin E. Cox September 04, 2018
News Conference News ESC 2018 SCOT-HEART: A Win for CT Angiography in Chest Pain Workup Prompts Cacophony of Reactions Shelley Wood August 31, 2018
News Conference News ESC 2018 High-STEACS: Sensitive Troponin Tests Rule Out MI, but Have No Impact on Hard Events Shelley Wood August 29, 2018
News Conference News ESC 2018 New ESC/EACTS Revascularization Guidelines Make Room for Radial First, STICH, and DES for All Michael O'Riordan August 29, 2018
News Conference News ESC 2018 Omega-3 Fatty Acids Fail to Reduce CVD Events in Diabetic Patients: ASCEND Michael O'Riordan August 26, 2018
News Conference News ESC 2018 CLARIFY: No Survival Benefit With Beta-Blockers Beyond 1 Year Post-MI in Stable CAD Shelley Wood August 25, 2018
News Conference News ESC 2018 CULPRIT-SHOCK: 1-Year Results Continue to Support Culprit-Only PCI for Shock Patients Todd Neale August 25, 2018
News Daily News ‘Classic’ Takotsubo? Not So Fast: Different Presentations Could Spell Diverse Prognoses Yael L. Maxwell August 16, 2018
News Daily News Faulting Salt? New PURE Analysis Argues Against Low Sodium Intake Todd Neale August 10, 2018
News Daily News Coronary Microvascular Dysfunction May Be a Marker of CV Risk in Obese Patients L.A. McKeown August 09, 2018
News Daily News Starting Low and Going Lower: Some Benefit to Very Low LDL Levels Michael O'Riordan August 02, 2018
News Daily News ESC Algorithm Safely Rules Out NSTEMI, but Caution May Be Warranted in the US Todd Neale August 01, 2018
News Daily News New Consensus Statement: NOAC and Clopidogrel for Most A-fib Patients Treated With PCI Michael O'Riordan July 31, 2018
News Conference News SCCT 2018 Marijuana May Muddle a Chest Pain Diagnosis, CTA Study Hints Yael L. Maxwell July 18, 2018
News Daily News Rivaroxaban Offers Net Reduction in Fatal or Irreversible Events in ACS: ATLAS ACS-2 TIMI-51 Michael O'Riordan July 06, 2018
News Daily News SGLT2 Inhibitors Work in Type 2 Diabetes Across Levels of CV Risk, Renal Function Todd Neale July 02, 2018